{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:27:59Z","timestamp":1762507679674,"version":"3.44.0"},"reference-count":16,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,2,6]]},"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>We describe the clinical course of a 64-year-old woman with stage IVa lung adenocarcinoma who presented with over 1\u2009month of fatigue, unintentional weight loss and emesis. She initiated treatment with nivolumab immunotherapy 1\u2009year prior and had been tolerating the treatment well. A comprehensive workup revealed multiple endocrinological abnormalities consistent with hypophysitis leading to hypopituitarism in the form of central adrenal insufficiency and hypogonadism as well as a partially empty sella on imaging. This case demonstrates that while receiving novel forms of treatment such as immunotherapy, patients should be monitored closely for a wide range of adverse effects.<\/jats:p>","DOI":"10.1136\/bcr-2018-228135","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T05:08:12Z","timestamp":1552021692000},"page":"e228135","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Nivolumab-induced hypophysitis leading to hypopituitarism and secondary empty sella syndrome in a patient with non-small cell lung cancer"],"prefix":"10.1136","volume":"12","author":[{"given":"Jeremy","family":"Chang","sequence":"first","affiliation":[{"name":"Internal Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Tran","sequence":"additional","affiliation":[{"name":"Internal Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Kamel","sequence":"additional","affiliation":[{"name":"Internal Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnab","family":"Basu","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology, University of Southern California\u2014Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"key":"2025082700484366000_12.3.e228135.1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090847"},{"key":"2025082700484366000_12.3.e228135.2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp140768"},{"key":"2025082700484366000_12.3.e228135.3","doi-asserted-by":"crossref","first-page":"mdv383","DOI":"10.1093\/annonc\/mdv383","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"26","author":"Naidoo","year":"2015","journal-title":"Ann Oncol"},{"key":"2025082700484366000_12.3.e228135.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.0379"},{"key":"2025082700484366000_12.3.e228135.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5256.1734"},{"key":"2025082700484366000_12.3.e228135.6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.hoc.2014.02.002","article-title":"Immune checkpoint blockade","volume":"28","author":"Naidoo","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"2025082700484366000_12.3.e228135.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4075"},{"key":"2025082700484366000_12.3.e228135.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"2025082700484366000_12.3.e228135.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200694"},{"key":"2025082700484366000_12.3.e228135.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.12.009"},{"key":"2025082700484366000_12.3.e228135.11","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0208"},{"key":"2025082700484366000_12.3.e228135.12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11102-015-0671-4","article-title":"Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights","volume":"19","author":"Faje","year":"2016","journal-title":"Pituitary"},{"key":"2025082700484366000_12.3.e228135.13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008002"},{"key":"2025082700484366000_12.3.e228135.14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2169\/internalmedicine.9074-17","article-title":"Isolated adrenocorticotropin deficiency due to nivolumab-induced hypophysitis in a patient with advanced lung adenocarcinoma: a case report and literature review","volume":"57","author":"Ohara","year":"2018","journal-title":"Intern Med"},{"key":"2025082700484366000_12.3.e228135.15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1507\/endocrj.EJ16-0161","article-title":"Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma","volume":"63","author":"Okano","year":"2016","journal-title":"Endocr J"},{"key":"2025082700484366000_12.3.e228135.16","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1004"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-228135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:48:53Z","timestamp":1756280933000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-228135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,7]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1136\/bcr-2018-228135"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-228135","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}